sima管理团队
这个人很懒，什么都没有留下～
7
文章
0
粉丝
-
Patient Death in Trial Marks Setback for Allogene’s Off-the-shelf CAR-T
On August 1, 2025, local time, Allogene Therapeutics (hereinafter referred to as “Al…
-
CellOrigin’s DLL3 CAR-T Accepted by CDE, China Leads Global DLL3 Therapeutic Development
August 2, 2025 – The clinical trial application for SNC115, a DLL3-targeting chimeric anti…
-
Q2 Loss of $800 Million, 10% Workforce Reduction, CEO Rejects M&A Deal
During the Q2 earnings call, when asked whether Moderna was considering M&A deals in C…
-
World’s First Clinical Improvement! Sun Yat-sen Memorial Hospital Collaborates with Shize Bio to Advance Universal iPSC-Derived Neural Cell Therapy for Spinal Cord Injury
On July 17, 2025, a landmark achievement was made in the “world’s first”…
-
DrugTimes BD Project | A Anti-C3 Nanobody Indicated for Geographic Atrophy
Geographic Atrophy (GA), a late-stage form of age-related macular degeneration (AMD), has …
-
Seeking Innovative Ophthalmology Drug Projects, Considering Small Molecules, Monoclonal/Polyclonal Antibodies, Nucleic Acid Drugs, Molecular Glues, Gene Therapies…
Driven by the rising prevalence of eye diseases and increased public awareness of healthca…
-
Global market opportunity! Buyers in urgent need of CNS-related products/platforms.
On July 9, 2025, Novartis struck another deal, acquiring Sironax’s “Brain Deli…
点击查看更多
